Physiopathology of the migraine attack and the mechanisms of action of antimigraine agents: Recent findings in animals;Physiopathologie de la crise migraineuse et modes d'action des antimigraineux: Dernieres nouvelles du monde animal

Pathologie Biologie

Volumn 48, Issue 7, 2000, Pages 593-607

  Mick, G ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

5 HT(1B D) receptor; Central sensitization; CGRP; Cortical spreading depression; Peripheral sensitization; Trigeminal nociception; Trigeminovascular model; Vasoconstriction

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; SEROTONIN AGONIST; SUBSTANCE P;

ANIMAL MODEL; HEADACHE; MIGRAINE; NEUROGENIC INFLAMMATION; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; REVIEW; SENSITIZATION; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NUCLEUS; VASOCONSTRICTION; VASODILATATION;

ANIMAL; BRAIN; ENGLISH ABSTRACT; HUMAN; MIGRAINE; MODELS, ANIMAL; SEROTONIN AGONISTS; SPREADING CORTICAL DEPRESSION; VASOCONSTRICTOR AGENTS;

EID: 0033779125     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. 1-like agonist, blocks neurogenic plasma protein extravasation in dura mater
2. Neurogenically mediated plasma extravasation in dura mater: Effects of ergots alkaloids. A possible mechanism of action in vascular headache
3. The mode of action of the antimigraine drug sumatriptan
4. Migraine pain associated with middle cerebral artery dilatation: Reversal by sumatriptan
5. Controversis in headache. The mode of action of sumatriptan is vascular?
6. Inhibition of trigeminal neurons by intravenous administration of the 5-HT(1D) receptor agonist zolmitriptan: Are brain stem sites a therapeutic target in migraine?
7. The visceral organ brain: Implications for he pathophysiology of vascular headache
8. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
9. Migraine as a model of neurogenic ischemia
10. Bench to bedside: What have we learnt recently about headache?
11. Pathogenesis of migraine
12. Pathophysiology of the migraine aura: The spreading depression theory
13. Cerebral blood flow changes in migraine: Methods, observations and hypotheses
14. Cerebral blood flow in migraine with aura
15. Spreading depression of activity in the cerebral cortex
16. Propagation of cortical spreading depression
17. Mechanims involved in spreading depression
18. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices
19. The nature of chick's magnesium sensitive retinal spreading depression
20. Extracellular ionic variations during spreading depression
21. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression
22. Inhibition of cortical spreading depression by L-107,324, a novel antagonist at the glycine site of the NMDA receptor complex
23. Calcium waves
24. Spreading cortical depression determines acute cellular damage in the hippocampal slice during oxygen/glucose deprivation
25. Differential downregulation of protein kinase C isoforms in spreading depression
26. Cortical blood flow changes during spreading depression in cats
27. Cerebral hemodynamics during cortical spreading depression in rabbits
28. An experimental model of migraine with aura: Cortical hypoperfusion following spreading depression in the awake and freely moving rat
29. Neuromagnetic findings in migraine. Preliminary findings
30. Cortical spreading depression recorded from the human brain using a multiparametric monitoring system
31. The occipital cortex is hyperexcitable in migraine: Evidence from TMS, fMRI, NMR spectroscopy and MEG studies
32. 2+ channels in mammalian central neurons
33. Immunochemical identification and subcellular distribution of the α1A subunits of brain calcium channels
34. Ischemia may be the primary cause of the neurological deficits in classical migraine
35. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classical migraine
36. Timing and topography of cerebral blood flow, aura and headache during migraine attacks
37. Neurovascular cortical spreading phenomenon during spontaneous visual aura
38. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache
39. Differential effects on the internal and external carotid circulation of the monkey evoked by locus coeruleus stimulation
40. Possible mechanim of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression
41. Cortical spreading depression does not result in the release of calcitonin gene related peptide into the external jugular vein of the cat: Relevance to human migraine
42. Brain stem activation in spontaneous human migraine attacks
43. Les recepteurs centraux de la serotonine
44. 5-HT moduline, a new peptide specifically interactive with the serotoninergic system: Physiopathological implications
45. + current
46. Glutamate release in human cerebral cortex and its modulation by 5-HT acting at h5-HT(1D) receptors
47. Sympathectomy enhances plasma protein extravasation induced by stimulation of the sphenopalatin ganglion in the rat dura mater
48. Long term superior cervical sympathectomy induces mast cell hyperplasia and increases serotonin and histamine content in the rat dura mater
49. Evidence that 5-HT(1D) receptors mediate inhibition of sympathetic ganglionic transmission in anaesthesied cats
50. Serotonin in migraine: Theories, animal models and emerging therapies
51. Neuropeptides in headache
52. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura matter and c-fos mRNA expression in trigeminal nucleus caudalis of rats
53. Regulation of calcitonin gene-related peptide secretion by a serotoninergic antimigraine drug
54. Vanilloid receptors on sensory nerves mediate the vasodilatator action of anandamide
55. Ineffectiveness of neurokinin-1 antagonist in acute migraine: A crossover study
56. Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks
57. Characterization of LY334370 as a pharmacological tool to study 5-HT(1F) receptors-binding affinities, brain penetration and activity in the neurogenic aural inflammation model of migraine
58. Vasoconstriction in human isolated middle meningeal arteries: Determining the contribution of 5-HT(1B) and 5-HT(1F) receptor activation
59. Glutamate and 5-HT(1F) receptors modulate trigeminal pain in rats
60. The conformationally restricted sumatriptan analogue CP-122,288 blocks neurogenic inflammation, but is not effective in aborting migraine attacks: Results of two controlled clinical studies
61. Endothelial expression of the 5-HT(1B) antimigraine drug receptor in rat and human brain microvessels
62. Mechanisms of migraine headache
63. The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis
64. MK-801 reduces fos-like immunoreactivity in trigeminocervical complex of cat
65. Direct evidence for central sites of action of zolmitriptan (311C90): An autoradiographic study in the cat
66. Effects of PNU 109,291, a selective 5-HT(1D) receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis
67. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism
68. The changing sensitivity in the life of the nociceptor
69. Central hyperexcitability triggered by noxious stimuli
70. Natural noxious stimulation can induce long-term increase of spinal nociceptive responses
71. NMDA receptor mechanisms contribute to neuroplasticity induced in caudalis nociceptive neurons by tooth pulp stimulation
72. Responses of neurons in feline trigeminal subnucleus caudalis (medullary dorsal horn) to cutaneous, intraoral, and muscle afferent stimuli
73. Anatomical properties of brainstem trigeminal neurons that respond to electrical stimulation of dural blood vessels
74. Preclinical investigations into the central mechanisms of migraine
75. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons
76. Mechanisms of migraine headache
77. Cutaneous allodynia during migraine. A new neurological finding and a new insight into the pathophysiology
78. Sensitization of meningeal sensory neurons and the origin of headaches
79. Differential effects of the 5-HT(1B/1D) receptor agonist naratriptan on trigeminal versus spinal nociceptive responses
80. Naratriptan inhibits central trigeminal activity by 5-HT(1B/D) receptor
81. Calcitonin gene-related peptide induces vasodilatation by nitric oxide
82. Activation of meningeal 5-HT(2B) receptors: An early step in the generation of migraine headache?
83. The role of the periaqueductal gray (PAG) in the pathogenesis of migraine
84. Descending inhibition and facilitation of nociception
85. Brainstem stimulation inhibits trigeminal neurons in the cat
86. Rizatriptan has central antinociceptive effects against aurally evoked responses
87. Long lasting sensory alterations induced by a brief electrical stimulation of C-fibers in the rat